Results
|
16321.
|
|
|
16322.
|
|
|
16323.
|
|
|
16324.
|
|
|
16325.
|
|
|
16326.
|
|
|
16327.
|
|
|
16328.
|
|
|
16329.
|
|
|
16330.
|
|
|
16331.
|
|
|
16332.
|
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. [electronic resource] by
- Min, H
- Morony, S
- Sarosi, I
- Dunstan, C R
- Capparelli, C
- Scully, S
- Van, G
- Kaufman, S
- Kostenuik, P J
- Lacey, D L
- Boyle, W J
- Simonet, W S
Producer: 20010322
In:
The Journal of experimental medicine vol. 192
Availability: No items available.
|
|
16333.
|
|
|
16334.
|
|
|
16335.
|
|
|
16336.
|
|
|
16337.
|
|
|
16338.
|
|
|
16339.
|
|
|
16340.
|
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. [electronic resource] by
- Burgess, T L
- Qian, Y
- Kaufman, S
- Ring, B D
- Van, G
- Capparelli, C
- Kelley, M
- Hsu, H
- Boyle, W J
- Dunstan, C R
- Hu, S
- Lacey, D L
Producer: 19990601
In:
The Journal of cell biology vol. 145
Availability: No items available.
|